Y. . Shen, X. . Chen, H. . Zhang, and . H. Hu, “Long-term cost-effectiveness analysis of onceweekly Semaglutide versus Dulaglutide for the treatment of type 2 diabetes after the renewal of the national drug reimbursement list in China”, Health Decision, vol. 2, no. S1, Jul. 2024.